Application of hyaluronic acid as carriers in drug delivery

References

• Alaniz L, Cabrera PV, Blanco G, et al. (2016). Interaction of CD44 with different forms of hyaluronic acid. Its role in adhesion and migration of tumor cells. Cell Commun Adhes 9:117–30.
   Web of Science ®Google Scholar
• Asayama S, Nogawa M, Takei Y, et al. (1998). Synthesis of novel polyampholyte comb-type copolymers consisting of a poly(L-lysine) backbone and hyaluronic acid side chains for a DNA carrier. Bioconjug Chem 9:476–81.
   PubMed Web of Science ®Google Scholar
• Bot PT, Hoefer IE, Piek JJ, et al. (2008). Hyaluronic acid: targeting immune modulatory components of the extracellular matrix in atherosclerosis. Curr Med Chem 15:786–91.
   PubMed Web of Science ®Google Scholar
• Cado G, Aslam R, Séon L, et al. (2013). Self‐defensive biomaterial coating against bacteria and yeasts: polysaccharide multilayer film with embedded antimicrobial peptide. Adv Funct Mater 23:4801–9.
   Web of Science ®Google Scholar
• Chen B, Miller RJ, Dhal PK. (2014). Hyaluronic acid-based drug conjugates: state-of-the-art and perspectives. J Biomed Nanotechnol 10:4–16.
   PubMed Web of Science ®Google Scholar
• Cho HJ, Hong YY, Koo H, et al. (2011). Self-assembled nanoparticles based on hyaluronic acid-ceramide (HA-CE) and Pluronic®, for tumor-targeted delivery of docetaxel. Biomaterials 32:7181–90.
   PubMed Web of Science ®Google Scholar
• Choi KY, Min KH, Yoon HY, et al. (2011). PEGylation of hyaluronic acid nanoparticles improves tumor targetability in vivo. Biomaterials 32:1880–9.
   PubMed Web of Science ®Google Scholar
• Chu LY. (2005). Controlled release systems for insulin delivery. Expert Opin Ther Pat 15:1147–55.
   Web of Science ®Google Scholar
• Chun KW, Lee JB, Sun HK, et al. (2005). Controlled release of plasmid DNA from photo-cross-linked pluronic hydrogels. Biomaterials 26:3319–26.
   PubMed Web of Science ®Google Scholar
• Coradini D, Zorzet S, Rossin R, et al. (2004). Inhibition of hepatocellular carcinomas in vitro and hepatic metastases in vivo in mice by the histone deacetylase inhibitor HA-But. Clin Cancer Res 10:4822–30.
   PubMed Web of Science ®Google Scholar
• El KN, Bochot A, Huang N, et al. (2015). Effect of liposomes on rheological and syringeability properties of hyaluronic acid hydrogels intended for local injection of drugs. Int J Pharm 487:187–96.
   PubMed Web of Science ®Google Scholar
• Eliaz RE, Szoka FC., Jr. (2001). Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. Cancer Res 61:2592–601.
   PubMed Web of Science ®Google Scholar
• Fan X, Zhao X, Qu X, et al. (2015). pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect. Int J Pharm 496:644–53.
   PubMed Web of Science ®Google Scholar
• Fan Y, Yao J, Du R, et al. (2013). Ternary complexes with core-shell bilayer for double level targeted gene delivery: in vitro and in vivo evaluation. Pharm Res 30:1215–27.
   PubMed Web of Science ®Google Scholar
• Galer CE, Sano D, Ghosh SC, et al. (2011). Hyaluronic acid–paclitaxel conjugate inhibits growth of human squamous cell carcinomas of the head and neck via a hyaluronic acid-mediated mechanism. Oral Oncol 47:1039–47.
   PubMed Web of Science ®Google Scholar
• Gratieri T, Gelfuso GM, Rocha EM, et al. (2010). A poloxamer/chitosan in situ forming gel with prolonged retention time for ocular delivery. Eur J Pharm Biopharm 75:186–93.
   PubMed Web of Science ®Google Scholar
• Hahn SK, Kim JS, Shimobouji T. (2007). Injectable hyaluronic acid microhydrogels for controlled release formulation of erythropoietin. J Biomed Mater Res A 80A:916–24.
   Web of Science ®Google Scholar
• Hirakura T, Yasugi K, Nemoto T, et al. (2010). Hybrid hyaluronan hydrogel encapsulating nanogel as a protein nanocarrier: new system for sustained delivery of protein with a chaperone-like function. J Control Release 142:483–9.
   PubMed Web of Science ®Google Scholar
• Jang YL, Ku SH, Jin S, et al. (2014). Hyaluronic acid-siRNA conjugate/reducible polyethylenimine complexes for targeted siRNA delivery. J Nanosci Nanotechnol 14:7388–94.
   PubMed Web of Science ®Google Scholar
• Jiang T, Zhang Z, Zhang Y, et al. (2012). Dual-functional liposomes based on pH-responsive cell-penetrating peptide and hyaluronic acid for tumor-targeted anticancer drug delivery. Biomaterials 33:9246–58.
   PubMed Web of Science ®Google Scholar
• Jong A, Wu CH, Gonzalesgomez I, et al. (2012). Hyaluronic acid receptor CD44 deficiency is associated with decreased Cryptococcus neoformans brain infection. J Biol Chem 287:15298–306.
   PubMed Web of Science ®Google Scholar
• Kim AP, Yellen P, Yun YH, et al. (2005). Delivery of a vector encoding mouse hyaluronan synthase 2 via a crosslinked hyaluronan film. Biomaterials 26:1585–93.
   PubMed Web of Science ®Google Scholar
• Ko YK, Kim SH, Jeong JS, et al. (2007). Preparation and characterization of hyaluronic acid loaded PLGA scaffold by emulsion freeze-drying method. Polymer Korea 31:505–11.
   Web of Science ®Google Scholar
• Lee DE, Kim AY, Hong YY, et al. (2012a). Amphiphilic hyaluronic acid-based nanoparticles for tumor-specific optical/MR dual imaging. J Mater Chem 22:10444–7.
   Web of Science ®Google Scholar
• Lee H, Mok H, Lee S, et al. (2007). Target-specific intracellular delivery of siRNA using degradable hyaluronic acid nanogels. J Control Release 119:245–52.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Ghosh SC, Han HD, et al. (2012b). Metronomic activity of CD44-targeted hyaluronic acid-Paclitaxel in ovarian carcinoma. Clin Cancer Res 18:4114–21.
   PubMed Web of Science ®Google Scholar
• Lee S, Youn YS, Lee SH, et al. (2006). PEGylated glucagon-like peptide-1 displays preserved effects on insulin release in isolated pancreatic islets and improved biological activity in db/db mice. Diabetologia 49:1608–11.
   PubMed Web of Science ®Google Scholar
• Liu E, Zhou Y, Liu Z, et al. (2015). Cisplatin loaded hyaluronic acid modified TiO2 nanoparticles for neoadjuvant chemotherapy of ovarian cancer. J Nanomater 2015:1–8.
   Web of Science ®Google Scholar
• Lv H, Zhang S, Wang B, et al. (2006). Toxicity of cationic lipids and cationic polymers in gene delivery. J Control Release 114:100–9.
   PubMed Web of Science ®Google Scholar
• Ma Y, Yang Q, Wang L, et al. (2012). Repeated injections of PEGylated liposomal topotecan induces accelerated blood clearance phenomenon in rats. Eur J Pharm Sci 45:539–45.
   PubMed Web of Science ®Google Scholar
• Mayol L, Biondi M, Russo L, et al. (2014). Amphiphilic hyaluronic acid derivatives toward the design of micelles for the sustained delivery of hydrophobic drugs. Carbohydr Polym 102:110–16.
   PubMed Web of Science ®Google Scholar
• Motokawa K, Hahn SK, Nakamura T, et al. (2006). Selectively crosslinked hyaluronic acid hydrogels for sustained release formulation of erythropoietin. J Biomed Mater Res A 78A:459–65.
   Web of Science ®Google Scholar
• Ossipov DA. (2010). Nanostructured hyaluronic acid-based materials for active delivery to cancer. Expert Opin Drug Deliv 7:681–703.
   PubMed Web of Science ®Google Scholar
• Park JK, Shim JH, Kang KS, et al. (2011a). Solid free-form fabrication of tissue-engineering scaffolds with a poly(lactic-co-glycolic acid) grafted hyaluronic acid conjugate encapsulating an intact bone morphogenetic protein–2/poly(ethylene glycol) complex. Adv Funct Mater 21:2906–12.
   Web of Science ®Google Scholar
• Park K, Hong SW, Hur W, et al. (2011b). Target specific systemic delivery of TGF-β siRNA/(PEI-SS)-g-HA complex for the treatment of liver cirrhosis. Biomaterials 32:4951–8.
   PubMed Web of Science ®Google Scholar
• Park K, Lee MY, Kim KS, et al. (2010). Target specific tumor treatment by VEGF siRNA complexed with reducible polyethyleneimine-hyaluronic acid conjugate. Biomaterials 31:5258–65.
   PubMed Web of Science ®Google Scholar
• Peer D, Margalit R. (2004). Loading mitomycin C inside long circulating hyaluronan targeted nano-liposomes increases its antitumor activity in three mice tumor models. Int J Cancer 108:780–9.
   PubMed Web of Science ®Google Scholar
• Prokopović VZ, Duschl C, Volodkin DV. (2015). Hyaluronic acid/poly‐L‐lysine multilayers coated with gold nanoparticles: cellular response and permeability study. Polym Adv Technol 25:1342–8.
   Web of Science ®Google Scholar
• Rivkin I, Cohen K, Koffler J, et al. (2010). Paclitaxel-clusters coated with hyaluronan as selective tumor-targeted nanovectors. Biomaterials 31:7106–14.
   PubMed Web of Science ®Google Scholar
• Rosso F, Quagliariello V, Tortora C, et al. (2013). Cross-linked hyaluronic acid sub-micron particles: in vitro and in vivo biodistribution study in cancer xenograft model. J Mater Sci Mater Med 24:1473–81.
   PubMed Web of Science ®Google Scholar
• Saravanakumar G, Deepagan VG, Jayakumar R, et al. (2014). Hyaluronic acid-based conjugates for tumor-targeted drug delivery and imaging. J Biomed Nanotechnol 10:17–31.
   PubMed Web of Science ®Google Scholar
• Shen Y, Wang B, Lu Y, et al. (2011). A novel tumor-targeted delivery system with hydrophobized hyaluronic acid-spermine conjugates (HHSCs) for efficient receptor-mediated siRNA delivery. Int J Pharm 414:233–43.
   PubMed Web of Science ®Google Scholar
• Shoham N, Sasson AL, Lin FH, et al. (2013). The mechanics of hyaluronic acid/adipic acid dihydrazide hydrogel: towards developing a vessel for delivery of preadipocytes to native tissues. J Mech Behav Biomed Mater 28:320–31.
   PubMed Web of Science ®Google Scholar
• Sung MH, Park C, Choi JC, et al. (2014). Hyaluronidase inhibitor containing poly-gamma-glutamic acid as an effective component. US, US8916141.
   Google Scholar
• Surendrakumar K, Martyn GP, Hodgers EC, et al. (2003). Sustained release of insulin from sodium hyaluronate based dry powder formulations after pulmonary delivery to beagle dogs. J Control Release 91:385–94.
   PubMed Web of Science ®Google Scholar
• Thomas RG, Moon MJ, Lee H, et al. (2015). Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy. Carbohydr Polym 131:439–46.
   PubMed Web of Science ®Google Scholar
• Widjaja LK, Bora M, Chan PN, et al. (2014). Hyaluronic acid‐based nanocomposite hydrogels for ocular drug delivery applications. J Biomed Mater Res A 102:3056–65.
   PubMed Web of Science ®Google Scholar
• Xin D, Ying W, Xiang J. (2010). The use of amino acid linkers in the conjugation of paclitaxel with hyaluronic acid as drug delivery system: synthesis, self-assembled property, drug release, and in vitro efficiency. Pharm Res 27:380–9.
   PubMed Web of Science ®Google Scholar
• Xu P, Kc RB. (2016). Ternary gene delivery system for gene therapy and methods of its use. US 20160008289 A1.
   Google Scholar
• Yao J, Fan Y, Du R, et al. (2010). Amphoteric hyaluronic acid derivative for targeting gene delivery. Biomaterials 31:9357–65.
   PubMed Web of Science ®Google Scholar
• Yu M, Jambhrunkar S, Thorn P, et al. (2013). Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells. Nanoscale 5:178–83.
   PubMed Web of Science ®Google Scholar
• Yun YH, Goetz DJ, Yellen P, et al. (2004). Hyaluronan microspheres for sustained gene delivery and site-specific targeting. Biomaterials 25:147–57.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang H, Ma Z, et al. (2014). Effects of pharmaceutical PEGylation on drug metabolism and its clinical concerns. Expert Opin Drug Metab Toxicol 10:1691–702.
   PubMed Web of Science ®Google Scholar